We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Loss of Notch1 Signaling Leads to Skin Cancer in Mouse Model

By LabMedica International staff writers
Posted on 16 Jul 2009
Researchers using a line of genetically engineered mice lacking the Notch1 signaling protein in some skin cells have found that a state of persistent inflammation can lead to the generation of skin cancers from both normal cells and those lacking the Notch1 gene.

Investigators at Washington University School of Medicine (St. Louis, MO, USA) created a line of mice with both normal and Notch1 null skin cells. These animals developed thickened and inflamed patches of skin due to an increased number of blood vessels and local inflammation, which were a result of missing Notch1 signaling in some of the cells. Interestingly, these animals were prone to developing skin papillomas that originated from both normal and Notch 1 null skin cells. About 10% of these papillomas progressed to basal cell carcinomas.

While Notch1 is generally considered a tumor-suppressing gene in skin cells, Notch1 null patches of skin encouraged angiogenesis and the production of growth factors. The persistent expression of these factors provided cells with nutrients and proliferation signals that promoted tumor formation in the mutant skin tissue and in neighboring normal skin cells with active Notch1 signaling.

"The chronic skin condition in the mice led to the growth of skin tumors," said senior author Dr. Raphael Kopan, professor of developmental biology and dermatology at Washington University School of Medicine. "And what we learned from this process fit very well with the emerging realization that a tumor's surroundings play a critical role in its development. The study suggests that as researchers develop drugs, they should be mindful of their potential effect on the skin, particularly those that cause chronic damage to skin integrity. Studies like ours help define the range of possible complications in drug design and help tailor therapies to avoid them."

"It is very reasonable to assume that chronic wounds in a variety of tissues have similar characteristics," said Dr. Kopan. "The skin of these mice is easy to monitor and will give us the ability to further analyze tumor promotion and find answers that might apply to any chronic wound."

Related Links:

Washington University School of Medicine



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Portable POCT Blood Gas Analyzer
BD100
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
16 Jul 2009  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
16 Jul 2009  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
16 Jul 2009  |   BioResearch